With eight employees, FluGen was founded in 2007 and received initial support from angel investors and other sources including WARF. Based in the University Research Park in Madison, its first product to enter clinical trials will be the vaccine delivery patch. The market for influenza products alone was estimated at more than $6 billion for 2010.